Purpose and Objectives

At the conclusion of this Conference, attending participants should be able to:

• experience an opportunity and environment for constructive discussion of GMP and product quality related issues;
• gain insightful knowledge about forthcoming policies related to pharmaceutical ingredient safety;
• hear directly from the leaders of the FDA and industry on matters concerning pharmaceutical production and distribution;
• gain knowledge about FDA's approach to current issues like pharmaceutical ingredient safety, process validation, ICH , counterfeit drugs, and global drug safety;
  and
• review and discuss FDA enforcement activities related to the pharmaceutical industry